
Avoid co-administration of ixazomib with strong CYP3A inducers (e.g., rifampicin, phenytoin sodium, carbamazepine, and St. John's wort).
from FDA,2024.07
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unresectable or metastati···【more】
Recommended:1092026-08-01
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cancer cells.Which drugs ···【more】
Recommended:1192026-08-01
Ixazomib Citrate is approved for use in combination with lenalidomide and dexamethasone for the trea···【more】
Recommended:1032026-08-01
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations. As a prescription-only medic···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:109
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cancer cells.Which drugs interact with Ixazomib?Concurrent use of this product with any of the following ···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:119
Ixazomib Citrate is approved for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior lin···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:103

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: